VELTASSA is a Oral Powder, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Vifor Pharma, Inc.. The primary component is Patiromer.
Product ID | 53436-084_0259a872-3b9a-445c-8dc4-86f6aadf129a |
NDC | 53436-084 |
Product Type | Human Prescription Drug |
Proprietary Name | VELTASSA |
Generic Name | Patiromer |
Dosage Form | Powder, For Suspension |
Route of Administration | ORAL |
Marketing Start Date | 2015-10-23 |
Marketing Category | NDA / NDA |
Application Number | NDA205739 |
Labeler Name | Vifor Pharma, Inc. |
Substance Name | PATIROMER |
Active Ingredient Strength | 8 g/1 |
Pharm Classes | Potassium Binder [EPC],Potassium Ion Binding Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2015-10-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA205739 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-05-01 |
Marketing Category | NDA |
Application Number | NDA205739 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-10-23 |
Marketing Category | NDA |
Application Number | NDA205739 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-05-01 |
Marketing Category | NDA |
Application Number | NDA205739 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-10-23 |
Marketing Category | NDA |
Application Number | NDA205739 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-10-23 |
Ingredient | Strength |
---|---|
PATIROMER | 8.4 g/1 |
SPL SET ID: | bf002984-d6c9-46df-aecb-a07733f763c1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
53436-084 | VELTASSA | patiromer |
53436-168 | VELTASSA | patiromer |
53436-252 | VELTASSA | patiromer |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VELTASSA 86235807 4933010 Live/Registered |
Relypsa, Inc. 2014-03-28 |